Nasal corticosteroids market to reach $9.87 billion by 2030 at 8.0% cagr, driven by increasing prevalence of respiratory diseases and allergic conditions.
Read More
Narcotic drugs market to reach $18.79 billion by 2030 at 5.2% cagr, driven by rising incidence of chronic diseases requiring long-term pain management.
Read More
Nanotechnology based medical devices market to reach $23.24 billion by 2030 at 36.9% cagr, driven by increasing adoption of personalized medicine and precision healthcare tools.
Read More
Nanopharmaceuticals market to reach $254.37 billion by 2030 at 17.7% cagr, driven by rising prevalence of chronic diseases and need for advanced therapeutic options.
Read More
Nanomedicine drug delivery market to reach $252.69 billion by 2030 at 15.4% cagr, driven by growing adoption of personalized medicine and targeted drug delivery systems.
Read More
Nanomedicine market to reach $786.46 billion by 2030 at 16.0% cagr, driven by rising burden of complex and chronic diseases across the globe.
Read More
Nanomaterials in personalized medicine market to reach $674.28 billion by 2030 at 11.3% cagr, driven by increasing demand for personalized medicine and targeted therapeutic solutions.
Read More
Nanocarriers Market Forecast Highlights Expansion From $13.74 Billion To $26.74 Billion Through 2030
Nanocarriers market to reach $26.74 billion by 2030 at 18.1% cagr, driven by rising demand for personalized medicines and advanced drug delivery technologies.
Read More
Naloxone Spray Market Expected To Reach $2428.62 Billion By 2030 As Growth Accelerates At 24.6% CAGR
Naloxone spray market to reach $2428.63 billion by 2030 at 24.6% cagr, driven by increasing demand for telemedicine and rapid response to opioid overdose cases.
Read More
Myeloproliferative disorders drugs market to reach $12.17 billion by 2030 at 4.6% cagr, driven by rise in incidence of myeloproliferative disorders and aging population.
Read More